Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction: One-year follow-up of a large prospective cohort

Archives of Internal Medicine

Volumn 163, Issue 8, 2003, Pages 965-971

  Stenestrand, Ulf ^a   Wallentin, Lars ^b  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; NITRATE; RETEPLASE; STREPTOKINASE; TENECTEPLASE;

AGED; AGING; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CAUSE OF DEATH; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; GERIATRIC PATIENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; ST SEGMENT ELEVATION; STROKE; SURVIVAL RATE; TREATMENT OUTCOME; AGE; COMPARATIVE STUDY; CORONARY CARE UNIT; ELECTROCARDIOGRAPHY; METHODOLOGY; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; STATISTICS;

AGE FACTORS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CEREBRAL HEMORRHAGE; CORONARY CARE UNITS; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 0037471556     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.8.965     Document Type: Article

References (20)

1. Goldberg RJ, McCormick D, Gurwitz JH, Yarzebski J, Lessard D, Gore JM. Agerelated trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol. 1998;82: 1311-1317.
2. Rosengren A, Spetz CL, Koster M, Hammar N, Alfredsson L, Rosen M. Sex differences in survival after myocardial infarction in Sweden: data from the Swedish National Acute Myocardial Infarction Register. Eur Heart J. 2001;22:314-322.
3. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients [published correction appears in Lancet. 1994;343:742]. Lancet. 1994;343:311-322.
4. White HD. Thrombolytic therapy in the elderly. Lancet. 2000;356:2028-2030.
5. Gottlieb S, Goldbourt LJ, Boyko V, et al, for the SPRINT and Thrombolytic Survey Groups. Improved outcome of elderly patients (> or=75 years of age) with acute myocardial infarction from 1981-1983 to 1992-1994 in Israel: Secondary Prevention Reinfarction Israel Nifedipine Trial. Circulation. 1997;95:342-350.
6. Berger AK, Radford MJ, Wang Y, Krumholz HM. Thrombolytic therapy in older patients. J Am Coll Cardiol. 2000;36:366-374.
7. Ayanian JZ, Braunwald E. Thrombolytic therapy for patients with myocardial Infarction who are older than 75 years: do the risks outweigh the benefits? Circulation. 2000;101:2224-2226.
8. Herlitz J, Hartford M, Karlson BW, Dellborg M, Kallstrom G, Karlsson T. One-year mortality after acute myocardial infarction prior to and after the implementation of a widespread use of thrombolysis and aspirin: experiences from the community of Goteborg, Sweden. Cardiology. 1998;89:216-221.
9. Thiemann DR, Coresh J, Schulman SP, Gerstenblith G, Oetgen WJ, Powe NR. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation. 2000;101:2239-2246.
10. Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285:430-436.
11. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90:583-612.
12. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127(8, pt 2):757-763.
13. Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol. 1999;150:327-333.
14. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988;2: 349-360.
15. White HD, Barbash GI, Califf RM, et al, for the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries Trial. Age and outcome with contemporary thrombolytic therapy: results from the GUSTO-I trial. Circulation. 1996; 94:1826-1833.
16. Gore JM, Granger CB, Simoons ML, et al, for the Global Use of Strategies to Open Occluded Coronary Arteries. Stroke after thrombolysis: mortality and functional outcomes in the GUSTO-I trial. Circulation. 1995;92:2811-2818.
17. O'Connor CM, Califf RM, Massey EW, et al. Stroke and acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis. J Am Coll Cardiol. 1990;16:533-540.
18. Simoons ML, Maggioni AP, Knatterud G, et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet. 1993;342:1523-1528.
19. Brass LM, Lichtman JH, Wang Y, Gurwitz JH, Radford MJ, Krumholz HM. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project. Stroke. 2000;31:1802-1811.
20. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996;28:1328-1428.